Clinical Trial Update: Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluated post-dose changes in exhaled nitric oxide after treatment with the FP/SAL combination product Advair in asthma, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: Sandoz | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08